Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Greupink

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Paediatric Drugs|October 6, 2022
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special PopulationJolien J M Freriksen, Joyce E M van der Heijden, Marika A de Hoop-Sommen, et al.
Clinical Pharmacology and Therapeutics|August 9, 2023
Physiologically-Based Pharmacokinetic Modeling for Drug Dosing in Pediatric Patients: A Tutorial for a Pragmatic Approach in Clinical CareJoyce E M van der Heijden, Jolien J M Freriksen, Marika A de Hoop-Sommen, et al.
Frontiers in Pediatrics|December 11, 2023
Pragmatic physiologically-based pharmacokinetic modeling to support clinical implementation of optimized gentamicin dosing in term neonates and infants: proof-of-conceptMarika A de Hoop-Sommen, Joyce E M van der Heijden, Jolien J M Freriksen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 30, 2012
Interaction of digitalis-like compounds with p-glycoproteinElnaz Gozalpour, Hanneke G M Wittgen, Jeroen J M W van den Heuvel, et al.
Lancet (London, England)|November 2, 2024
Striving for balance in decisions on antenatal pharmacotherapyCharlotte Koldeweij, Verna Aam Jans, Catriona Waitt, et al.
Chemical Research in Toxicology|April 10, 2014
In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitorsTina Ritschel, Susanne M A Hermans, Marieke Schreurs, et al.
Frontiers in Pediatrics|July 22, 2024
Getting the dose right using physiologically-based pharmacokinetic modeling: dexamethasone to prevent post-extubation stridor in children as proof of conceptJoyce E M van der Heijden, Marika de Hoop-Sommen, Noa Hoevenaars, et al.
Journal of Hepatology|August 9, 2005
Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cellRick Greupink, Hester I Bakker, Catharina Reker-Smit, et al.
European Journal of Pharmacology|September 30, 2014
Convallatoxin: a new P-glycoprotein substrateElnaz Gozalpour, Rick Greupink, Albert Bilos, et al.
American Journal of Obstetrics and Gynecology|September 3, 2020
Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivoJolien J M Freriksen, Miriam Meijerhof, Joris van Drongelen, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Paediatric Drugs|October 6, 2022
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special PopulationJolien J M Freriksen, Joyce E M van der Heijden, Marika A de Hoop-Sommen, et al.
Clinical Pharmacology and Therapeutics|August 9, 2023
Physiologically-Based Pharmacokinetic Modeling for Drug Dosing in Pediatric Patients: A Tutorial for a Pragmatic Approach in Clinical CareJoyce E M van der Heijden, Jolien J M Freriksen, Marika A de Hoop-Sommen, et al.
Frontiers in Pediatrics|December 11, 2023
Pragmatic physiologically-based pharmacokinetic modeling to support clinical implementation of optimized gentamicin dosing in term neonates and infants: proof-of-conceptMarika A de Hoop-Sommen, Joyce E M van der Heijden, Jolien J M Freriksen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 30, 2012
Interaction of digitalis-like compounds with p-glycoproteinElnaz Gozalpour, Hanneke G M Wittgen, Jeroen J M W van den Heuvel, et al.
Lancet (London, England)|November 2, 2024
Striving for balance in decisions on antenatal pharmacotherapyCharlotte Koldeweij, Verna Aam Jans, Catriona Waitt, et al.
Chemical Research in Toxicology|April 10, 2014
In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitorsTina Ritschel, Susanne M A Hermans, Marieke Schreurs, et al.
Frontiers in Pediatrics|July 22, 2024
Getting the dose right using physiologically-based pharmacokinetic modeling: dexamethasone to prevent post-extubation stridor in children as proof of conceptJoyce E M van der Heijden, Marika de Hoop-Sommen, Noa Hoevenaars, et al.
Journal of Hepatology|August 9, 2005
Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cellRick Greupink, Hester I Bakker, Catharina Reker-Smit, et al.
European Journal of Pharmacology|September 30, 2014
Convallatoxin: a new P-glycoprotein substrateElnaz Gozalpour, Rick Greupink, Albert Bilos, et al.
American Journal of Obstetrics and Gynecology|September 3, 2020
Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivoJolien J M Freriksen, Miriam Meijerhof, Joris van Drongelen, et al.
Pageof 8